Neuroscience
Antenatal Depression
16%
Anti-Inflammatory
22%
Antidepressant
74%
Antipsychotic
29%
Behavior (Neuroscience)
32%
Bipolar Disorder
22%
Blood Brain Barrier
13%
Blood Plasma
24%
Body Mass Index
16%
C-Reactive Protein
56%
Cannabis
20%
Cognitive Function
15%
Cortisol
100%
Cortisol Awakening Response
20%
Depressive Disorder
41%
Functional Magnetic Resonance Imaging
17%
Gene Expression
26%
Glucocorticoid
53%
Glucocorticoid Receptor
46%
Hippocampus
15%
Hyperactivity
16%
Hypothalamic-Pituitary-Adrenal Axis
74%
Icosapentaenoic Acid
16%
In Vitro
15%
Interferon
20%
Interferon Alfa
23%
Interleukin 1
14%
Interleukin 6
46%
Kynurenine
13%
Longitudinal Study
14%
Major Depressive Disorder
89%
Mental Disorder
45%
Messenger RNA
15%
Meta-Analysis
33%
Microglia
16%
Minocycline
12%
Mood Disorder
15%
Negative Syndrome
13%
Neurogenesis
41%
Omega 3 Fatty Acid
21%
Pediatric Trauma
30%
Placebo
18%
positron emission tomographic scan
14%
Postpartum Depression
21%
Prednisolone
14%
Prefrontal Cortex
15%
Prenatal Stress
13%
Psychiatry
28%
Transcriptomics
13%
Treatment-Resistant Depression
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
7%
Antenatal Depression
5%
Anti-Inflammatory Drug
7%
Antidepressant
48%
Biological Marker
14%
Bipolar Disorder
7%
C Reactive Protein
15%
Citalopram
5%
Comorbidity
9%
Cytokine
16%
Depressive Disorder
16%
Diseases
34%
Docosahexaenoic Acid
8%
Glucocorticoid
34%
Glucocorticoid Receptor
28%
Hepatitis C
6%
Hepatitis C Virus
5%
Hydrocortisone
27%
Hyperactivity
6%
Icosapentaenoic Acid
12%
Infection
5%
Inflammation
58%
Interferon
7%
Interleukin 1
11%
Interleukin 6
19%
Kynurenine
12%
Major Depression
28%
Messenger RNA
8%
Minocycline
7%
Mood Disorder
5%
Nervous System Inflammation
5%
Normal Human
5%
Omega-3 Fatty Acid
17%
Perinatal Depression
5%
Placebo
12%
Postnatal Depression
7%
Prednisolone
7%
Psychopharmacology
7%
Psychotropic Agent
10%
Side Effect
9%
Treatment Resistant Depression
10%
Tumor Necrosis Factor
10%
Medicine and Dentistry
Antidepressant
18%
Arm
5%
Biological Marker
16%
Bipolar Disorder
9%
C Reactive Protein
12%
Cardiovascular Disease
5%
Clinical Trial
9%
Cohort Analysis
5%
Cortisol Awakening Response
9%
Cost-Effectiveness Analysis
5%
COVID-19
12%
Depressive Disorder
25%
Disease
6%
Diseases
28%
Glucocorticoid
9%
Glucocorticoid Receptor
7%
Health Outcomes
6%
Hydrocortisone
26%
Hypothalamic-Pituitary-Adrenal Axis
28%
Immune System
15%
Infection
5%
Interleukin 1
5%
Interleukin 6
15%
Ischemic Heart Disease
7%
Major Depressive Episode
25%
Mediator
5%
Mental Disorder
11%
Mental Health
37%
Meta-Analysis
16%
Metabolic Syndrome
8%
Minocycline
7%
Mood Disorder
6%
Negative Syndrome
6%
Offspring
11%
Omega-3 Fatty Acid
7%
Patient with Depression
8%
Pediatric Trauma
7%
Placebo
9%
Postpartum Depression
14%
Postpartum Psychosis
9%
Prevalence
6%
Prospective Cohort Study
5%
Psychiatrist
5%
Psychiatry
7%
Psychopharmacology
5%
Randomized Controlled Trial
12%
Systematic Review
23%
Treatment Resistant Depression
7%
Treatment Response
6%
Tumor Necrosis Factor
8%
